Company / Shareholders' Equity
Bruker Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$2.5B
FY2025
5-year range
$1.1B / $2.5B
FY2021-FY2025
Trend
+37.9%
vs FY2024
Sector context
#49 of 166
Health Care
What the data says
At $2.5B, Bruker's shareholders' equity ranks #49 of 166 in the Health Care sector. Shareholders' Equity has increased for 9 consecutive years, from $686M in FY2016 to $2.5B in FY2025.
Based on SEC 10-K filings.
$2.5B in FY2025 with a 5-year CAGR of +20.6%.
Improved from $1.4B to $2.5B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +30.2%
- 5-Year CAGR
- +20.6%
- 10-Year CAGR
- -
Sector benchmark
#49 of 166 in Health CareTop 30% of 166This company $2.5B Sector average $5.3B
▼
-53.2% below sector average
Key checks
Key Insights
- Bruker's shareholders' equity has grown for 9 consecutive years.
- 5-year CAGR of +20.6%, indicating consistent growth.
- In FY2025, shareholders' equity increased 37.9% year-over-year.
- Ranks #49 out of 166 companies in the Health Care sector.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.5B | +37.9% |
| FY2024 | $1.8B | +29.3% |
| FY2023 | $1.4B | +23.6% |
| FY2022 | $1.1B | +4.0% |
| FY2021 | $1.1B | +11.4% |
| FY2020 | $961.2M | +6.0% |
| FY2019 | $906.8M | +1.1% |
| FY2018 | $896.6M | +23.6% |
| FY2017 | $725.4M | +5.7% |
| FY2016 | $686.4M | -5.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026